New Proprietary Target Discovery and Validation Platform Integrates Multiomics, Contingent AI, Phenoclustering, and CRISPR Screens to Accelerate Drug Discovery LOS ANGELES, (GLOBE ...
This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...
Labroots: Scalable 2D and 3D human hepatocyte platforms for target validation and compound screening in early drug discovery pipelines of liver diseases
Scalable 2D and 3D human hepatocyte platforms for target validation and compound screening in early drug discovery pipelines of liver diseases
News Medical: Combining CRISPR gene editing and microfluidics for 3D target validation
EurekAlert!: Advanced Science: Insilico Medicine utilized AI technology for novel target discovery and drug repurposing to treat endometriosis
Advanced Science: Insilico Medicine utilized AI technology for novel target discovery and drug repurposing to treat endometriosis
News Medical: OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate
OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round. The Company ...
OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate
abc27: Genomics launches Mystra: the world's first and original AI-enabled human genetics platform, now available to transform drug target discovery and clinical development
Genomics launches Mystra: the world's first and original AI-enabled human genetics platform, now available to transform drug target discovery and clinical development
Markets Insider: Promatix Biosciences Highlights the Power of its Logic-Gated Proteomics-Driven Bispecific Discovery Platform to Expand the Tumour-Selective Target Space for Next-Generation ...